Drug Discovery & Pharmaceuticals

RSS
Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

21 Feb 2022
Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

21 Feb 2022
N-glycosylation blockers reduce SARS-CoV-2 infection

N-glycosylation blockers reduce SARS-CoV-2 infection

20 Feb 2022
Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

20 Feb 2022
Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

20 Feb 2022
Ensitrelvir, a novel SARS-CoV-2 antiviral

Ensitrelvir, a novel SARS-CoV-2 antiviral

17 Feb 2022
New METPlatform allows researchers to test drugs for possible use in brain metastases

New METPlatform allows researchers to test drugs for possible use in brain metastases

17 Feb 2022
Researchers overcome key challenge in creating sulfur-based medicines

Researchers overcome key challenge in creating sulfur-based medicines

15 Feb 2022
Novel molecule shows ability to inhibit the replication of all coronaviruses

Novel molecule shows ability to inhibit the replication of all coronaviruses

10 Feb 2022
Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

7 Feb 2022
Cocktail of two chemicals could help slow down age-related muscular decline

Cocktail of two chemicals could help slow down age-related muscular decline

7 Feb 2022
Wistar researchers takes a promising step in the direction of developing HIV vaccine

Wistar researchers takes a promising step in the direction of developing HIV vaccine

4 Feb 2022
SARS-CoV-2 human challenge study offers novel insights into viral kinetics

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

3 Feb 2022
Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

2 Feb 2022
New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

2 Feb 2022
New machine-learning model could speed up the process of developing new medicines

New machine-learning model could speed up the process of developing new medicines

1 Feb 2022
Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

28 Jan 2022
Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

28 Jan 2022
Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

27 Jan 2022
Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

24 Jan 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback